Robert F. Grover

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*

Ángel Crespo López, José A. Lorente, Jay S. Steingrub et al. · Critical Care Medicine · 2004 · 917 citations

Hypoxic ventilatory drive in normal man

John V. Weil, E. Byrne-Quinn, I. E. Sodal et al. · Journal of Clinical Investigation · 1970 · 429 citations · Full text

Pulmonary Circulation, Ventilation, Physiology +11

Acquired attenuation of chemoreceptor function in chronically hypoxic man at high altitude

John V. Weil, E. Byrne-Quinn, I. E. Sodal et al. · Journal of Clinical Investigation · 1971 · 205 citations · Full text

Asthma, Physical Activity, Kinesiology +21

Abnormal Circulatory Responses to High Altitude in Subjects with a Previous History of High-Altitude Pulmonary Edema

Herbert N. Hultgren, Robert F. Grover, L. Howard Hartley · Circulation · 1971 · 201 citations · Full text

Acute Lung Injury, Hypertension, High-altitude Pulmonary Edema +23

An open-label dose escalation study of the nitric oxide synthase inhibitor, NG-methyl-L-arginine hydrochloride (546C88), in patients with septic shock

Robert F. Grover, David Zaccardelli, Gene Colice et al. · Critical Care Medicine · 1999 · 200 citations